BiomX Inc. (PHGE) is a publicly traded Healthcare sector company. As of May 21, 2026, PHGE trades at $0.61 with a market cap of $4.66M and a P/E ratio of 0.03. PHGE moved +56.95% today. Year to date, PHGE is -73.59%; over the trailing twelve months it is -94.25%. Its 52-week range spans $0.36 to $22.06. Analyst consensus is neutral with an average price target of $0.00. Rallies surfaces PHGE's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
PHGE financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. PHGE recently traded at $0.61. Market cap is $4.66M. P/E ratio is 0.03. Revenue is $0.
| Metric | Value |
|---|---|
| Price | $0.61 |
| Market Cap | $4.66M |
| P/E Ratio | 0.03 |
| EPS | $22.19 |
| Dividend Yield | 0.00% |
| 52-Week High | $22.06 |
| 52-Week Low | $0.36 |
| Volume | 3.87M |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-36.20M |
| Gross Margin | 0.00% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $0 | $-36.20M | $22.19 |
| 2024 | $0 | $-17.73M | $1.47 |
| 2023 | $0 | $-26.17M | $0.51 |
| 2022 | $-26.84M | $-28.32M | $0.95 |
1 analysts cover PHGE: 0 strong buy, 0 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $0.00.